Literature DB >> 30248487

The role of mitochondria in NLRP3 inflammasome activation.

Qiuyun Liu1, Danyan Zhang1, Diyu Hu1, Xiangmei Zhou2, Yang Zhou3.   

Abstract

The NLRP3 inflammasome is a multiprotein platform which is activated upon cellular infection or stress. Its activation leads to caspase-1-dependent secretion of proinflammatory cytokines like interleukin-1β (IL-1β) and IL-18, and an inflammatory form of cell death termed as pyroptosis. Recent studies have unveiled the pivotal roles of mitochondria in initiation and regulation of the NLRP3 (nucleotide-binding domain, leucine-rich-repeat containing family, pyrin domain-containing 3) inflammasome. NLRP3 activators induce mitochondrial destabilization, NLRP3 deubiquitination, linear ubiquitination of ASC, and externalization or release of mitochondria-derived molecules such as cardiolipin and mitochondrial DNA. These molecules bind to NLRP3 that is translocated on mitochondria and activate the NLRP3 inflammasome. Here we review recently described mechanisms by which mitochondria regulate NLRP3 inflammasome activation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium; Cardiolipin; Reactive oxygen species; Ubiquitination; mtDNA

Mesh:

Substances:

Year:  2018        PMID: 30248487     DOI: 10.1016/j.molimm.2018.09.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  97 in total

1.  Topical Application of the Antimicrobial Agent Triclosan Induces NLRP3 Inflammasome Activation and Mitochondrial Dysfunction.

Authors:  Lisa M Weatherly; Hillary L Shane; Sherri A Friend; Ewa Lukomska; Rachel Baur; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

2.  NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.

Authors:  Hayate Javed; Ramasamy Thangavel; Govindhasamy Pushpavathi Selvakumar; Iuliia Dubova; Noah Schwartz; Mohammad Ejaz Ahmed; Smita Zaheer; Duraisamy Kempuraj; Shankar Iyer; Asgar Zaheer; Mohammad Moshahid Khan
Journal:  Int Immunopharmacol       Date:  2020-04-04       Impact factor: 4.932

3.  Redox Role of ROS and Inflammation in Pulmonary Diseases.

Authors:  Li Zuo; Denethi Wijegunawardana
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Crosstalk between ER stress, NLRP3 inflammasome, and inflammation.

Authors:  Wei Li; Ting Cao; Chunyi Luo; Jialun Cai; Xiangping Zhou; Xinhua Xiao; Shuangquan Liu
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-24       Impact factor: 4.813

Review 5.  Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease.

Authors:  Pankaj Prasun; Ilona Ginevic; Kimihiko Oishi
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

Review 6.  Sepsis-induced myocardial dysfunction: the role of mitochondrial dysfunction.

Authors:  Hang Yang; Zhaocai Zhang
Journal:  Inflamm Res       Date:  2021-03-08       Impact factor: 4.575

7.  Mitochondrial Oxidative Phosphorylation Complex Regulates NLRP3 Inflammasome Activation and Predicts Patient Survival in Nasopharyngeal Carcinoma.

Authors:  I-Che Chung; Lih-Chyang Chen; Ngan-Ming Tsang; Wen-Yu Chuang; Tzu-Chieh Liao; Sheng-Ning Yuan; Chun-Nan OuYang; David M Ojcius; Chih-Ching Wu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2019-11-13       Impact factor: 5.911

Review 8.  The NLRP3 Inflammasome and Its Role in Sepsis Development.

Authors:  Lucinéia Gainski Danielski; Amanda Della Giustina; Sandra Bonfante; Tatiana Barichello; Fabricia Petronilho
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 9.  Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

Authors:  Awanish Mishra; Ritam Bandopadhyay; Prabhakar Kumar Singh; Pragya Shakti Mishra; Neha Sharma; Navneet Khurana
Journal:  Metab Brain Dis       Date:  2021-08-13       Impact factor: 3.584

Review 10.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.